Primary Mitochondrial Disease Clinical Trial
Official title:
A Prospective Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)
This is an observational study of patients with Primary Mitochondrial Disease with either signs or symptoms suggestive of myopathy. The Investigator will identify potential patients through existing medical records and one on-site visit.
An observational study of patients with presumed Primary Mitochondrial Disease designed to better characterize and correlate symptoms and signs of myopathy and genetic test results and the use of commonly prescribed treatments. The study will help define and identify a subject population for a future trial of an investigational product to treat primary mitochondrial disease associated with signs and symptoms of myopathy. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05972954 -
OMT-28 in Patients With Primary Mitochondrial Disease (PMD) (PMD-OPTION)
|
Phase 2 | |
| Recruiting |
NCT05250375 -
Mitochondrial Myopathy Rating Scale
|
||
| Terminated |
NCT02976038 -
Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
|
Phase 2 | |
| Active, not recruiting |
NCT05650229 -
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
|
Phase 2 | |
| Completed |
NCT02805790 -
Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study
|
Phase 2 |